Volume | 979,102 |
|
|||||
News | - | ||||||
Day High | 0.455 | Low High |
|||||
Day Low | 0.4059 |
Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
Aethlon Medical Inc | AEMD | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
0.4229 | 0.4059 | 0.455 | 0.4301 | 0.401 |
Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
---|---|---|---|---|---|
1,825 | 979,102 | US$ 0.4383835 | US$ 429,222 | - | 0.3704 - 5.00 |
Last Trade | Type | Quantity | Price | Currency |
---|---|---|---|---|
15:24:06 | 4 | US$ 0.4459 | USD |
Aethlon Medical Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
1.13M | 2.62M | - | 574k | -12.03M | -4.59 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Aethlon Medical News
Date | Time | Source | News Article |
---|---|---|---|
5/17/2024 | 15:05 | Edgar (US Regulatory) | Form 8-K - Current report |
5/16/2024 | 23:15 | Edgar (US Regulatory) | Form EFFECT - Notice of Effectiveness |
5/16/2024 | 15:05 | Edgar (US Regulatory) | Form 424B4 - Prospectus [Rule 424(b)(4)] |
5/15/2024 | 08:27 | Edgar (US Regulatory) | Form POS AM - Post-Effective amendments for registration.. |
5/15/2024 | 08:15 | PR Newswire (US) | Aethlon Medical Announces Pricing of $4.7 Million Public.. |
5/13/2024 | 16:30 | Edgar (US Regulatory) | Form S-1/A - General form for registration of securities.. |
5/10/2024 | 07:01 | Edgar (US Regulatory) | Form 8-K - Current report |
5/10/2024 | 07:01 | PR Newswire (US) | Aethlon Medical Reports Positive Results From an In Vitro.. |
2/21/2024 | 07:01 | PR Newswire (US) | Aethlon Medical Enters Into Materials Transfer Agreement for.. |
2/14/2024 | 16:15 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
2/14/2024 | 15:15 | Edgar (US Regulatory) | Form 8-K - Current report |
2/14/2024 | 15:15 | PR Newswire (US) | Aethlon Medical Announces Fiscal Third Quarter Financial.. |
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical AEMD Price Data
Period †| Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 1.05 | 1.25 | 0.3704 | 0.5370301 | 2,974,669 | -0.625 | -59.52% |
1 Month | 1.45 | 1.79 | 0.3704 | 0.905996 | 1,741,558 | -1.03 | -70.69% |
3 Months | 1.72 | 1.85 | 0.3704 | 0.9137498 | 596,452 | -1.30 | -75.29% |
6 Months | 1.66 | 2.3499 | 0.3704 | 0.9454391 | 292,449 | -1.24 | -74.40% |
1 Year | 3.10 | 5.00 | 0.3704 | 2.02 | 241,204 | -2.68 | -86.29% |
3 Years | 17.10 | 124.90 | 0.3704 | 45.22 | 1,316,791 | -16.68 | -97.51% |
5 Years | 4.276 | 124.90 | 0.3704 | 37.73 | 1,194,953 | -3.85 | -90.06% |
Aethlon Medical Description
Aethlon Medical Inc is a medical technology company. It is focused on addressing unmet needs in health and biodefense. The company operates through two segments namely Aethlon for therapeutic applications, which represents its therapeutic business activities and ESI for diagnostic applications which signifies diagnostic business activities. It is focused on the development of Hemopurifier, a clinical-stage therapeutic device designed to combat cancer and to eliminate life-threatening viruses from the circulatory system. The company generates revenue from Aethlon segment. |